Filter
3100
Filtered Results: 3100
Text search:
adverse
health
outcomes
Featured
Recommendations
330
New Publications
798
Language
Document type
No document type
1725
Studies & Reports
513
Guidelines
501
Manuals
151
Strategic & Response Plan
99
Fact sheets
44
Training Material
42
Situation Updates
14
Resource Platforms
6
Infographics
2
Brochures
1
App
1
Online Courses
1
Countries / Regions
India
147
Global
130
Kenya
71
Western and Central Europe
71
South Africa
69
Ethiopia
66
Nigeria
53
Nepal
48
Uganda
41
Africa
40
Sierra Leone
39
Latin America and the Carribbean
36
Zambia
36
Tanzania
35
Malawi
34
Bangladesh
34
Ghana
33
Liberia
32
Philippines
31
Myanmar / Burma
30
Rwanda
25
Eastern Europe
24
South–East Asia Region
23
Cambodia
21
Namibia
21
Ukraine
18
Brazil
18
Zimbabwe
15
East and Southern Africa
15
Asia
14
Syria
13
Indonesia
13
Lesotho
12
Guinea
12
USA
12
Colombia
10
Mozambique
10
Eastern Europe and Central Asia
10
Botswana
10
West and Central Africa
9
Middle East and North Africa
9
Senegal
8
Thailand
7
Burkina Faso
7
Germany
7
Western Pacific Region
7
South Sudan
7
Eswatini/ Swaziland
7
Pakistan
7
Chile
6
Haiti
6
Congo, Democratic Republic of
6
Moldova
6
Russia
6
Sudan
6
Afghanistan
5
Venezuela
5
Jordan
5
Lebanon
5
Cameroon
4
Laos
4
Paraguay
4
United Kingdom
4
Argentina
4
Ecuador
4
Timor Leste/ East Timor
3
Benin
3
Egypt
3
Palestine
3
Somalia
3
Tajikistan
2
China
2
Singapore
2
Niger
2
Bolivia
2
Vietnam
2
Papua New Guinea
2
Yemen
2
Romania
2
Georgia
2
Central African Republic
2
Angola
2
Bhutan
2
Madagascar
2
North Macedonia
1
El Salvador
1
Australia
1
Gambia
1
Kazakhstan
1
Iran
1
Albania
1
Canada
1
Kyrgyzstan
1
Burundi
1
Peru
1
Bulgaria
1
Guinea-Bissau
1
Lithuania
1
Ireland
1
North America
1
Japan
1
Mauritius
1
Sri Lanka
1
Poland
1
Honduras
1
Mali
1
Libya
1
Iraq
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
991
Clinical Guidelines
365
Public Health
195
Women & Child Health
176
Key Resources
133
Capacity Building
46
Pharmacy & Technologies
29
Toolboxes
Mental Health
339
TB
235
COVID-19
225
HIV
221
Planetary Health
161
NCDs
89
Caregiver
87
Pharmacy
87
AMR
80
NTDs
72
Rapid Response
70
Ebola
58
Global Health Education
58
Disability
54
Conflict
50
Refugee
49
Zika
33
Natural Hazards
25
Health Financing Toolbox
19
Cholera
16
Polio
16
Specific Hazards
15
Social Ethics
6
Typhoon
1
These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB programmes, or their equivalents in Ministries of Health, stakeholders and technical organizations working on...
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto...
The COVID-19 Strategic Preparedness and Response Plan (SPRP) 2021 Monitoring and Evaluation Framework tracks global progress against the COVID-19 SPRP 2021 for the ten pillars of the public health response. The operational intelligence complements the epidemiologic information used to drive a global...
In the context of the coronavirus disease (COVID-19) pandemic response, WHO identifies young people as a priority target audience with specific concerns, experiences and behaviours. This policy brief provides relevant insights from behavioural evidence and a set of behavioural considerations for tho...
More than 700 000 people lose their life to suicide every year. The world is not on track to reach the 2030 suicide reduction targets. WHO advocates for countries to take action to prevent suicide, ideally through a comprehensive national suicide prevention strategy. Governments and communities can ...
This publication is based on the list of clinical interventions selected from clinical guidelines on prevention, screening, diagnosis, treatment, palliative care, monitoring and end of life care. This publication addresses medical devices for six types of cancer: breast, cervical, colorectal, leukem...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to...
The manual has been designed in a comprehensive manner, the aim being to provide a holistic approach to the short-term development of human resources, with a focus on primary care physicians. This is a reference manual meant for primary care physicians who will provide care to older people in primar...
When situations occur in which unwanted events are rightly or wrongly connected with vaccination, they may erode confidence in vaccines and the authorities delivering them. This document presents the scientific evidence behind WHO’s recommendations on building and restoring confidence in vaccines ...
Since the launch of the 2012–2020 World Health Organization (WHO) road map for the control, elim-ination and eradication of neglected tropical diseases (NTDs) (1), considerable progress against NTDs has been made. Between 2010 and 2020, the number of people requiring interventions against NTDs glo...
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i...
Note d’information scientifique, 17 juin 2021
interim guidance, 19 July 2021 (arabic version)
The meningitis road map has been designated as a flagship global strategy of the WHO’s Thirteenth General Programme of Work, 2019–2023 and is an essential component in achieving universal health coverage.
The road map will reinforce and combine with wider initiatives, such as those aimed at s...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
This publication is a companion document to the NDVP National Deployment and Vaccination Plans guidance, which provides a framework for countries to develop their national strategies. As countries face challenges with erratic vaccine supplies, use of multiple vaccine products with different charact...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
